mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.8 |
mRNA |
BIRB 0796 |
CTRPv2 |
pan-cancer |
AAC |
-0.0091 |
0.8 |
mRNA |
leptomycin B |
CTRPv2 |
pan-cancer |
AAC |
-0.0078 |
0.8 |
mRNA |
avrainvillamide |
CTRPv2 |
pan-cancer |
AAC |
-0.0094 |
0.8 |
mRNA |
ABT-199 |
CTRPv2 |
pan-cancer |
AAC |
-0.0099 |
0.8 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0076 |
0.8 |
mRNA |
ML210 |
CTRPv2 |
pan-cancer |
AAC |
0.0073 |
0.8 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0079 |
0.8 |
mRNA |
Mdivi-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.0079 |
0.8 |
mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
0.0085 |
0.8 |